Influence of uremia on cell viability and cytokine release of human peritoneal mesothelial cells

Kidney and Blood Pressure Research

Volumn 25, Issue 4, 2002, Pages 195-201

  Plum, J ^a   Fleisch, M C ^a   Razeghi, P ^a   Fussholler A ^a   Lordnejad, M R ^a   Grabensee, B ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Host defence; IL 6; IL 8; Peritoneal dialysis; Peritoneal mesothelial cells; Uremia

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOSINE TRIPHOSPHATE; CELL PROTEIN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; REAGENT; INTERLEUKIN 1; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ADULT; ARTICLE; BLOOD LEVEL; CATHETER; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPLANTATION; KIDNEY FAILURE; LONG TERM CARE; MALE; MASS; MESOTHELIUM CELL; PERITONEAL DIALYSIS; PERITONEUM CELL; PRIORITY JOURNAL; SUPERNATANT; UREMIA; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; CHEMOLUMINESCENCE; CHRONIC KIDNEY FAILURE; CYTOLOGY; EPITHELIUM; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PERITONEAL CAVITY; PHYSIOLOGY; PROTEIN SYNTHESIS;

ADENOSINE TRIPHOSPHATE; ADULT; CELL SURVIVAL; CELLS, CULTURED; CHEMILUMINESCENT MEASUREMENTS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL CAVITY; PROTEIN BIOSYNTHESIS; TETRAZOLIUM SALTS; THIAZOLES; UREMIA;

EID: 1842844238     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066347     Document Type: Article

References (27)

1. Cohen G, Haag-Weber M, Horl WH: Immune dysfunction in uremia. Kidney Int Suppl 1997;62:79-82.
2. Topley N: The host's initial response to peritoneal infection: The pivotal role of the mesothelial cell. Perit Dial Int 1995;15:116-117.
3. Topley N, Brown Z, Jörres A, et al: Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin 1β and tumor necrosis factor-α. Am J Pathol 1993;142:1876-1886.
4. Davenport A, Topley N, Williams JD: Control of polymorphonuclear leukocyte (PMN) migration across human peritoneal mesothelial cell (HPMC) monolayers (abstract). Annual EDTA-ERA Congress, Vienna. 1994.
5. Witowski J, Thiel A, Dechend K, Dunkel K, Fouquet N, Bender TO, Langrehr JM, Gahl GM, Frei U, Jörres A: Synthesis of C-X-C and C-C chemokines by human peritoneal fibrohlasts: Induction by macrophage-derived cytokines. Am J Pathol 2001;158:1441-1450.
6. Holmes CJ: Peritoneal host defense mechanisms in peritoneal dialysis. Kidney Int Suppl 1994;48:S58-S70.
7. Muijsken MA, Heezius HJCM, Verhoef J, Verbrugh HA: Role of mesothelial cells in peritoneal antibacterial defence. J Clin Pathol 1991;44:600-604.
8. Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA: Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994;45:890-896.
9. Herbelin A, Urena P, Nguyen AT, Zingraff J, Descamps-Latscha B: Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 1991;39:954-960.
10. Nakanishi I, Moutabarrik A, Okada N, Kitamura E, Hayashi A, Syouji T, Namiki M, Ishibashi M, Zaid D, Tsubakihara Y: Interleukin-8 in chronic renal failure and dialysis patients. Nephrol Dial Transplant 1994;9:1435-1442.
11. Douvdevani A, Rapoport J, Konforty A, Argov S, Ovnat A, Chaimovitz C: Human peritoneal mesothelial cells synthesize IL-1α and β. Kidney Int 1994;46:993-1001.
12. Topley N, Jörres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, Müller C, Coles GA, Davies M, Williams JD: Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1β and TNFα. Kidney Int 1993;43:226-233.
13. Betjes MGH, Tuk CW, Struijk DG, Krediet RT, Arisz L, Hart M, Beelen RHJ: Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-α, interleukin-1 and medium conditioned by macrophages cocultured with Staphylococcus epidemidis. J Infect Dis 1993;168:1202-1210.
14. Kishimoto T: The biology of interleukin-6. Blood 1989;74:1-10.
15. Goodman RB, Wood RG, Martin TR, Hanson-Painton O, Kinasewitz GT: Cytokine stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/1L-8. J Immunol 1992;148:457-465.
16. Zeillemaker AM, Mul FPJ, Hoynck Van Papendrecht AAGM, Kuijpers TW, Roos D. Leguit P, Verbrugh HA: Polarized secretion of interleukin-8 by human mesothelial cells: A role in neutrophil migration. Immunology 1995;84:227-232.
17. Brunkhorst R, Mahiout A: Pyruvate neutralizes peritoneal dialysate cytotoxicity: Maintained integrity and proliferation of cultured human mesothelial cells. Kidney Int 1995;48:177-1781.
18. Bronswijk van II, Verbrugh HA, Bos HJ, Heezius ECJM, Oe PL, Meulen van der J, Verhoef J: Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Peril Dial Int 1989;9:197-202.
19. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD: Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990;37:1563-1570.
20. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays. J Immunol Methods 1983;65:55-63.
21. Visser CE, Brouwer-Steenbergen JJE, Postmus PE, Meijer S, Struijk DG, Krediet RT, Beelen RHJ: Renal function influences interleukin-8 background production by cultured human mesothelial cells. Adv Perit Dial 1996;12:15-18.
22. Libetta C, De Nicola L, Rampino T, De Simone W, Memoli B: Inflammatory effects of peritoneal dialysis: Evidence of systemic monocyte activation. Kidney Int 1996;49:506-511.
23. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 1998;9:1285-1292.
24. Plum J, Fusshöller A, Schoenicke G, Busch T, Erren C, Fieseler C, Kirchgessner J, Passlick Deetjen J, Grabensee B: In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentration. Nephrol Dial Transplant 1997;12:1652-1660.
25. Mantovani A, Locati M, Allavena M, Sozzani S: The chemokine superfamily: Crosstalk with the IL-1 system. Immunobiology 1996;195:522-549.
26. Noronha IL, Niemir Z, Stein H, Waldherr R: Cytokines and growth factors in renal descase. Nephrol Dial Transplant 1995;10:775-786.
27. Plum J, Hermann A, Fusshöller A, Schönicke G, Donner A, Röhrborn A, Grabensee B: Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport. Kidney Int 2001:59(suppl 78):42-47.